Two clusters were associated with a high risk of fatal COVID-19 (38–45% mortality) and were defined as the lowest humoral response with the lowest circulating T-cells (C1), or as high IL-6 inflammatory response (C2). This evidence concerns the gene IL6 and COVID-19.